Ratings by Chardan
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 7/7/2026 | Keay Nakae | Metagenomi Inc | MGX | New Coverage | Buy (N/A) |
5.00 (N/A) |
1.25 (1.22) |
-2.4% | Details |
| 6/22/2026 | N/A | Tenax Therapeutics | TENX | New Coverage | Buy (N/A) |
27.00 (N/A) |
12.00 (15.72) |
31% | Details |
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
| 976 more... | |||||||||


